Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Impact of a remotely delivered, writing for publication program on publication outcomes of novice researchers.

Duncanson K, Webster EL, Schmidt DD.

Rural Remote Health. 2018 May;18(2):4468. doi: 10.22605/RRH4468. Epub 2018 May 24.

2.

Comparative functional anatomy of the epaxial musculature of dogs (Canis familiaris) bred for sprinting vs. fighting.

Webster EL, Hudson PE, Channon SB.

J Anat. 2014 Sep;225(3):317-27. doi: 10.1111/joa.12208. Epub 2014 Jun 10.

3.

Influencing population health performance: feedback from managers, population health staff and clinicians on the NSW Population Health Standards for Area Health Services.

Liddle JL, Jones TC, Lesjak MS, Milat AJ, Lyle DM, Webster EL.

N S W Public Health Bull. 2008 Jul-Aug;19(7-8):117-20.

PMID:
19007542
4.

Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.

Goff DC, Keefe R, Citrome L, Davy K, Krystal JH, Large C, Thompson TR, Volavka J, Webster EL.

J Clin Psychopharmacol. 2007 Dec;27(6):582-9.

PMID:
18004124
5.

The potential role of lamotrigine in schizophrenia.

Large CH, Webster EL, Goff DC.

Psychopharmacology (Berl). 2005 Sep;181(3):415-36. Epub 2005 Oct 12. Review.

PMID:
16001126
6.

Intrasellar and parasellar cellular schwannoma.

Perez MT, Farkas J, Padron S, Changus JE, Webster EL.

Ann Diagn Pathol. 2004 Jun;8(3):142-50. Review.

PMID:
15185261
7.

Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs.

Gabry KE, Chrousos GP, Rice KC, Mostafa RM, Sternberg E, Negrao AB, Webster EL, McCann SM, Gold PW.

Mol Psychiatry. 2002;7(5):474-83, 433.

8.

Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.

Webster EL, Barrientos RM, Contoreggi C, Isaac MG, Ligier S, Gabry KE, Chrousos GP, McCarthy EF, Rice KC, Gold PW, Sternberg EM.

J Rheumatol. 2002 Jun;29(6):1252-61.

PMID:
12064844
9.

CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists.

Hsin LW, Tian X, Webster EL, Coop A, Caldwell TM, Jacobson AE, Chrousos GP, Gold PW, Habib KE, Ayala A, Eckelman WC, Contoreggi C, Rice KC.

Bioorg Med Chem. 2002 Jan;10(1):175-83.

PMID:
11738619
10.

The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type.

Tian X, Hsin LW, Webster EL, Contoreggi C, Chrousos GP, Gold PW, Habib K, Ayala A, Eckelman WC, Jacobson AE, Rice KC.

Bioorg Med Chem Lett. 2001 Feb 12;11(3):331-3.

PMID:
11212103
11.

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.

Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW.

Proc Natl Acad Sci U S A. 2000 May 23;97(11):6079-84.

12.
13.

Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress.

Wong ML, Webster EL, Spokes H, Phu P, Ehrhart-Bornstein M, Bornstein S, Park CS, Rice KC, Chrousos GP, Licinio J, Gold PW.

Life Sci. 1999;65(4):PL53-8.

PMID:
10421433
14.

Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects.

Elenkov IJ, Webster EL, Torpy DJ, Chrousos GP.

Ann N Y Acad Sci. 1999 Jun 22;876:1-11; discussion 11-3. Review.

PMID:
10415589
15.

Urocortin and inflammation: confounding effects of hypotension on measures of inflammation.

Torpy DJ, Webster EL, Zachman EK, Aguilera G, Chrousos GP.

Neuroimmunomodulation. 1999 May-Jun;6(3):182-6.

PMID:
10213916
16.

A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep.

Chan EC, Falconer J, Madsen G, Rice KC, Webster EL, Chrousos GP, Smith R.

Endocrinology. 1998 Jul;139(7):3357-60.

PMID:
9645712
17.

Corticotropin-releasing hormone and inflammation.

Webster EL, Torpy DJ, Elenkov IJ, Chrousos GP.

Ann N Y Acad Sci. 1998 May 1;840:21-32. Review.

PMID:
9629233
18.

Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.

Bornstein SR, Webster EL, Torpy DJ, Richman SJ, Mitsiades N, Igel M, Lewis DB, Rice KC, Joost HG, Tsokos M, Chrousos GP.

Endocrinology. 1998 Apr;139(4):1546-55.

PMID:
9528933
19.

The role of corticotropin-releasing hormone in neuroendocrine-immune interactions.

Webster EL, Elenkov IJ, Chrousos GP.

Mol Psychiatry. 1997 Sep;2(5):368-72. Review.

PMID:
9322225
20.

Corticotropin-releasing hormone acts on immune cells to elicit pro-inflammatory responses.

Webster EL, Elenkov IJ, Chrousos GP.

Mol Psychiatry. 1997 Sep;2(5):345-6. No abstract available.

PMID:
9322220
21.

Autocrine-paracrine role of ovarian corticotropin-releasing hormone.

Mastorakos G, Ghizzoni L, Webster EL, Chrousos GP.

Ann N Y Acad Sci. 1997 Jun 17;816:27-41. No abstract available.

PMID:
9238253
22.
23.

Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary.

Mastorakos G, Webster EL, Friedman TC, Chrousos GP.

J Clin Invest. 1993 Aug;92(2):961-8.

24.

Expression and sequence of the gene for tissue inhibitor of metalloproteinases in patients with abdominal aortic aneurysms.

Tilson MD, Reilly JM, Brophy CM, Webster EL, Barnett TR.

J Vasc Surg. 1993 Aug;18(2):266-70.

PMID:
8350436
25.

Corticotropin-releasing hormone and its receptors in the ovary: physiological implications.

Mastorakos G, Webster EL, Chrousos GP.

Ann N Y Acad Sci. 1993 May 28;687:20-8. Review. No abstract available.

PMID:
8391775
26.

Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis.

Crofford LJ, Sano H, Karalis K, Webster EL, Goldmuntz EA, Chrousos GP, Wilder RL.

J Clin Invest. 1992 Dec;90(6):2555-64.

27.
28.

Role of brain, pituitary and spleen corticotropin-releasing factor receptors in the stress response.

De Souza EB, Grigoriadis DE, Webster EL.

Methods Achiev Exp Pathol. 1991;14:23-44. Review.

PMID:
1658548
29.

Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages.

Webster EL, Tracey DE, Jutila MA, Wolfe SA Jr, De Souza EB.

Endocrinology. 1990 Jul;127(1):440-52.

PMID:
2163323
30.

Functional corticotropin-releasing factor (CRF) receptors in mouse spleen: evidence from adenylate cyclase studies.

Webster EL, Battaglia G, De Souza EB.

Peptides. 1989 Mar-Apr;10(2):395-401.

PMID:
2547206
31.

Corticotropin-releasing factor (CRF) and interleukin-1 (IL-1) receptors in the brain-pituitary-immune axis.

De Souza EB, Webster EL, Grigoriadis DE, Tracey DE.

Psychopharmacol Bull. 1989;25(3):299-305.

PMID:
2560554
33.
34.
35.

Evidence that taste aversion learning induced by l-5-hydroxytryptophan is mediated peripherally.

Ervin GN, Carter RB, Webster EL, Moore SI, Cooper BR.

Pharmacol Biochem Behav. 1984 May;20(5):799-802.

PMID:
6610880

Supplemental Content

Loading ...
Support Center